ABBV
AbbVie Inc.
- Selling, general and administrative, 2025
- $14.0B
- YoY, 2025
- −5.0%
- 5-year CAGR
- +4.4%
- 10-year CAGR
- +8.2%
Selling, general and administrative
Selling, general and administrative by fiscal year
| Period | SG&A | YoY |
|---|---|---|
| 2025 | $14.0B | −5.0% |
| 2024 | $14.8B | +14.6% |
| 2023 | $12.9B | −15.6% |
| 2022 | $15.3B | +23.6% |
| 2021 | $12.3B | +9.3% |
| 2020 | $11.3B | +62.8% |
| 2019 | $6.9B | −6.2% |
| 2018 | $7.4B | +17.5% |
| 2017 | $6.3B | +7.0% |
| 2016 | $5.9B | −7.9% |
| 2015 | $6.4B | −17.3% |
| 2014 | $7.7B | +44.3% |
| 2013 | $5.4B | +7.3% |
| 2012 | $5.0B | −15.4% |
| 2011 | $5.9B | — |